199 related articles for article (PubMed ID: 17363734)
21. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Xanthou G; Duchesnes CE; Williams TJ; Pease JE
Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
[TBL] [Abstract][Full Text] [Related]
22. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
[TBL] [Abstract][Full Text] [Related]
23. Rat chemokine CXCL11: structure, tissue distribution, function and expression in cardiac transplantation models.
Mitsuhashi N; Wu GD; Zhu H; Kearns-Jonker M; Cramer DV; Starnes VA; Barr ML
Mol Cell Biochem; 2007 Feb; 296(1-2):1-9. PubMed ID: 17264982
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
[TBL] [Abstract][Full Text] [Related]
25. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
Colvin RA; Campanella GS; Manice LA; Luster AD
Mol Cell Biol; 2006 Aug; 26(15):5838-49. PubMed ID: 16847335
[TBL] [Abstract][Full Text] [Related]
26. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
[TBL] [Abstract][Full Text] [Related]
27. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
[TBL] [Abstract][Full Text] [Related]
28. Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11.
Dagan-Berger M; Feniger-Barish R; Avniel S; Wald H; Galun E; Grabovsky V; Alon R; Nagler A; Ben-Baruch A; Peled A
Blood; 2006 May; 107(10):3821-31. PubMed ID: 16368892
[TBL] [Abstract][Full Text] [Related]
29. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.
Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H
Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling.
Thompson BD; Jin Y; Wu KH; Colvin RA; Luster AD; Birnbaumer L; Wu MX
J Biol Chem; 2007 Mar; 282(13):9547-9555. PubMed ID: 17289675
[TBL] [Abstract][Full Text] [Related]
31. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
[TBL] [Abstract][Full Text] [Related]
32. The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts.
Kouroumalis A; Nibbs RJ; Aptel H; Wright KL; Kolios G; Ward SG
J Immunol; 2005 Oct; 175(8):5403-11. PubMed ID: 16210647
[TBL] [Abstract][Full Text] [Related]
33. NMR structure of CXCR3 binding chemokine CXCL11 (ITAC).
Booth V; Clark-Lewis I; Sykes BD
Protein Sci; 2004 Aug; 13(8):2022-8. PubMed ID: 15273303
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
Cox JH; Dean RA; Roberts CR; Overall CM
J Biol Chem; 2008 Jul; 283(28):19389-99. PubMed ID: 18411283
[TBL] [Abstract][Full Text] [Related]
35. Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca²⁺.
Tan X; Alrashdan YA; Alkhouri H; Oliver BG; Armour CL; Hughes JM
Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L790-802. PubMed ID: 23564506
[TBL] [Abstract][Full Text] [Related]
36. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.
Romagnani P; Annunziato F; Lasagni L; Lazzeri E; Beltrame C; Francalanci M; Uguccioni M; Galli G; Cosmi L; Maurenzig L; Baggiolini M; Maggi E; Romagnani S; Serio M
J Clin Invest; 2001 Jan; 107(1):53-63. PubMed ID: 11134180
[TBL] [Abstract][Full Text] [Related]
37. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
Colvin RA; Campanella GS; Sun J; Luster AD
J Biol Chem; 2004 Jul; 279(29):30219-27. PubMed ID: 15150261
[TBL] [Abstract][Full Text] [Related]
38. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis.
Pan J; Burdick MD; Belperio JA; Xue YY; Gerard C; Sharma S; Dubinett SM; Strieter RM
J Immunol; 2006 Feb; 176(3):1456-64. PubMed ID: 16424173
[TBL] [Abstract][Full Text] [Related]
39. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
40. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
Burns JM; Summers BC; Wang Y; Melikian A; Berahovich R; Miao Z; Penfold ME; Sunshine MJ; Littman DR; Kuo CJ; Wei K; McMaster BE; Wright K; Howard MC; Schall TJ
J Exp Med; 2006 Sep; 203(9):2201-13. PubMed ID: 16940167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]